Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Disease Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02065570
What this trial is testing

Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 514
Not applicableNot Yet RecruitingNCT07780045
What this trial is testing

SII and SIRI as Prognostic Biomarkers in Lupus Nephritis

Who this might be right for
Lupus NephritisSystemic Lupus ErythematosusKidney Diseases
Assiut University 100
Not applicableStudy completedNCT03178019
What this trial is testing

DPP4 Activity, Microvascular Reactivity and Inflammation

Who this might be right for
OverweightPre DiabetesDiabetes Mellitus Type 2 Without Complication
Rio de Janeiro State University 52
Testing effectiveness (Phase 2)Study completedNCT01179971
What this trial is testing

N-3 and n-6 Fatty Acids in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Charite University, Berlin, Germany 60
Not applicableStudy completedNCT01960439
What this trial is testing

Responsiveness of Endoscopic Evaluation in UC

Who this might be right for
Ulcerative Colitis
University of Western Ontario, Canada 194
Testing effectiveness (Phase 2)Looking for participantsNCT07012395
What this trial is testing

Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative ColitisInflammatory Bowel DiseasesColitis+1 more
Spyre Therapeutics, Inc. 645
Large-scale testing (Phase 3)Study completedNCT00036439
What this trial is testing

A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Centocor, Inc. 364
Testing effectiveness (Phase 2)Ended earlyNCT05581199
What this trial is testing

To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Immunovant Sciences GmbH 94
Large-scale testing (Phase 3)Ended earlyNCT02240121
What this trial is testing

One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease

Who this might be right for
Crohn's Disease
Bausch Health Americas, Inc. 80
Not applicableStudy completedNCT05019547
What this trial is testing

The Turkish Version of the Inflammatory Arthritis Facilitators and Barriers to Physical Activity

Who this might be right for
Axial Spondyloarthritis
Acibadem University 93
Large-scale testing (Phase 3)Study completedNCT01320436
What this trial is testing

Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Sheba Medical Center 50
Testing effectiveness (Phase 2)Ended earlyNCT00562887
What this trial is testing

Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's Disease

Who this might be right for
Crohn's Disease
Abbott 246
Testing effectiveness (Phase 2)Study completedNCT00718094
What this trial is testing

Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative Colitis

Who this might be right for
Mild to Moderately Active Ulcerative Colitis
University of Louisville 20
Testing effectiveness (Phase 2)Ended earlyNCT03298022
What this trial is testing

Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UC

Who this might be right for
Ulcerative Colitis
AltruBio Inc. 24
Large-scale testing (Phase 3)Study completedNCT00577473
What this trial is testing

Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)

Who this might be right for
Ulcerative Colitis
Warner Chilcott 301
Testing effectiveness (Phase 2)Study completedNCT01203631
What this trial is testing

Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease

Who this might be right for
InflammationCrohn's Disease
Janssen Research & Development, LLC 78
Testing effectiveness (Phase 2)Study completedNCT01275508
What this trial is testing

Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser Endomicroscopy of the Gut

Who this might be right for
Crohn's Disease
University of Erlangen-Nürnberg Medical School 25
Not applicableStudy completedNCT04297566
What this trial is testing

MICISPORT Survey : Questionnaire

Who this might be right for
Crohn's Disease
University Hospital, Montpellier 100
Testing effectiveness (Phase 2)Looking for participantsNCT06753565
What this trial is testing

L-carnitine Supplementation in Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis (RA)
German University in Cairo 60
Not applicableNot Yet RecruitingNCT07804511
What this trial is testing

Adapted Physical Activity for Persistent Fatigue in Patients With Inflammatory Bowel Disease in Remission

Who this might be right for
Inflammatory Bowel Diseases (IBD)FatigueCrohn Disease (CD)+1 more
University Hospital, Grenoble 120
Next Page